focus -WSS

focus

author：focus 2025-09-29 21:28:06 - browse：988

Silver Apple Watch — Charles Rex Arbogast/AP

Rune Labs, maker of an Apple Watch app that can track symptoms related to Parkinson’s disease, announced Thursday $12 million in funding led by Nexus NeuroTech, a new venture capital fund focused on brain disorders.

Rune in 2022 received Food and Drug Administration clearance for StrivePD, an Apple Watch app that uses the device’s sensors to track two Parkinson’s-related symptoms: tremors and dyskinesia, or the involuntary movements that are a side effect of medication. The app also collects sleep, activity, and medication data and can serve as a focal point for education and care management for people with Parkinson’s. The app can help users make day-to-day decisions about lifestyle and medication and help inform care decisions by providers. Rune also works with drug companies developing treatments for the disease.

Rune Labs CEO Brian Pepin told STAT the company will use the funds to push the adoption of its technology among health plans that can use it to manage care for their members with Parkinson’s disease. The company last year finalized a deal with “a large California health system” and now hopes to go out and sell to more organizations that have Medicare Advantage plans or other at-risk populations they serve. This requires an investment in business development staff and people to manage those relationships.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Mirador, a new biotech startup, launches with $400 million

WSS

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

'Patient friction coefficient' can gauge a clinical trial's patient burden

Pfizer, Moderna say biotech, pharma drug development is a sprint

Surgeons perform first xenotransplant using CRISPR'd pig kidney

6 surprising facts about sugar

Testing GLP

explore

focus

hotspot

Heart attack and stroke risk calculators need revising

With Wegovy coverage, Medicare patients may face high costs

Sports medicine is finally prioritizing gender equality

Medicare Advantage insurers pressure Biden for bigger payments

Virginia high school admissions case could be legal follow

Surgeons perform first xenotransplant using CRISPR'd pig kidney

23andMe had bad news about my health. I wish a person had delivered it

Chinese researcher claims birth of first gene

Dobbs anniversary: the lost opportunity of abortion as health care

This gene therapy has record $4.25 million price. It's saved children.

focus

Mirador, a new biotech startup, launches with $400 million

Biotech investment managers search for lucrative opportunities

Chinese researcher claims birth of first gene

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Testing GLP

Diabetes management: Digital health tools fall short, study says

focus

knowledge

leisure time

focus